CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP)

US23254L2079

7.6  -0.28 (-3.55%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
74.00K420.00K0.000.000.00
Operating Expenses
15.61M25.87M27.66M22.94M10.64M
Research and Development
9.29M19.16M20.27M15.48M4.76M
Selling, General, and Administrative Expenses
6.32M6.72M7.38M7.46M5.88M
Operating Income
-15.54M-25.45M-27.66M-22.94M-10.64M
Interest Income/Expense
-345.00K-148.00K440.00K60.00K60.00K
Other Income/Expense
N/A50.00K1.30M140.00K890.00K
Income Before Taxes
-15.83M-25.55M-25.92M-22.73M-9.68M
Income Tax
-2.40M-3.00M-4.72M-3.85M-1.24M
Net Income
-13.48M-22.76M-21.40M-19.09M-12.42M
EBITDA
-15.52M-25.42M-27.63M-22.90M-10.62M
 
Per Share Data
EPS Diluted Total Ops
-9.12-26.75-1.90-2.14-3.42
Non GAAP EPS
-9.40-27.23-10.30-2.14-3.87
 
Statistics
Profit Margin
-18217.57%-5418.10%N/AN/AN/A
Operating Profit Margin
-20994.59%-6060.24%N/AN/AN/A

All data in USD

Charts